期刊
PATHOLOGY RESEARCH AND PRACTICE
卷 219, 期 -, 页码 -出版社
ELSEVIER GMBH
DOI: 10.1016/j.prp.2021.153363
关键词
Long noncoding RNA; Ovarian cancer; Gynecological system; Prognosis; Biomarker
类别
资金
- Vice-Chancellor for Research Affairs of Kashan University of Medical Sciences [96117]
This study investigated the association between dysregulation of long non-coding RNAs (lncRNAs) and the prognosis of ovarian cancer patients. The results showed that altered lncRNAs expression was correlated with overall survival, progression-free survival, and disease-free survival in patients with ovarian cancer.
In recent years, tremendous research efforts have been focused on investigating the effect of dysregulation of lncRNAs on cancer progression, most of which confirm a positive link. This inspired us to conduct the present meta-analysis to explore whether aberrant expression of multiple lncRNAs has a role in patients? outcome in ovarian cancer. This comprehensive meta-analysis pertains to the evaluation of association between dysregulated lncRNAs expression level with eventual outcome and clinicopathological characteristics of ovarian cancer patients. We systematically searched PubMed, Web of Science, and Scopus to find all eligible articles. Pooled hazard ratios (HRs) and 95% confidence intervals (95% CIs) for overall survival, disease-free survival and progression free survival were measured with a fixed or random effects model. A total of 34 studies were included in the meta-analysis. Dysregulation of lncRNAs were contributed to shorter overall survival (34 studies, 1180 patients HR = 2.12, 95% CI: 1.73 ? 2.60, random-effects) in ovarian cancer. Furthermore, altered lncRNAs were also related to decreased progression-free survival (8 studies, 1180 patients HR: 1.88, 95% CI: (1.35?2.62) and disease-free survival (2 studies, 285 patients, HR: 6.07, 95% CI: 1.28?28.78) in this disease. Our analyses supported the robust prognostic significance of altered lncRNAs in ovarian cancer. However, more extended studies are encouraged to evaluate the clinical application potential of these lncRNAs in the prognosis evaluation of ovarian cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据